Clinical Trials Logo
  1. Home
  2. Juvenile Rheumatoid Arthritis
  3. NCT00078793

Registry of Etanercept (Enbrel®) In Children With Juvenile Rheumatoid Arthritis

Juvenile Rheumatoid Arthritis Clinical Trial

Official title:
Phase IV Registry of Etanercept (Enbrel®) In Children With Juvenile Rheumatoid Arthritis

Clinical Trial Summary

This study will evaluate long-term safety of etanercept with or without other DMARDs in children with polyarticular course or systemic juvenile rheumatoid arthritis (JRA) compared to a cohort of subjects with polyarticular or systemic JRA receiving methotrexate with or without other DMARDs.

Clinical Trial Description

n/a

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00078793
Study type Observational
Source Amgen
Contact
Status Completed
Phase N/A
Start date June 2000
Completion date January 2008
View Details
See also
  Status Clinical Trial Phase
Completed NCT00004420 - Study of Gammalinolenic Acid for Juvenile Rheumatoid Arthritis N/A
Completed NCT00090571 - Juvenile Rheumatoid Arthritis Research Registry
Recruiting NCT05545839 - Transition to Adulthood Through Coaching and Empowerment in Rheumatology N/A
Completed NCT00010335 - Pilot Study of Total Body Irradiation in Combination With Cyclophosphamide, Anti-thymocyte Globulin, and Autologous CD34-Selected Peripheral Blood Stem Cell Transplantation in Children With Refractory Autoimmune Disorders Phase 1
Completed NCT00690573 - Safety, Efficacy, and Pharmacokinetics of Adalimumab in Japanese Children With Juvenile Rheumatoid Arthritis Phase 3
Completed NCT00443430 - Trial of Early Aggressive Drug Therapy in Juvenile Idiopathic Arthritis Phase 4
Completed NCT03780959 - Safety and Efficacy of Etanercept (Recombinant Human Tumor Necrosis Factor Receptor Fusion Protein [TNFR:Fc]) in Children With Juvenile Rheumatoid Arthritis (JRA) Phase 2/Phase 3
Active, not recruiting NCT00006055 - Autologous Peripheral Blood Stem Cell Transplantation in Patients With Life Threatening Autoimmune Diseases N/A
Completed NCT00570934 - Supplementation With Vitamin D, Calcium or Both on Calcium Absorption and Bone Mineral Content in Children With JRA Phase 3
Recruiting NCT05715463 - Rheumatology-based Adaptive Intervention for Social Determinants and Health Equity N/A
Completed NCT00289094 - Randomized Fixed Bearing vs Mobile Bearing Cruciate Retaining TKA N/A
Terminated NCT00078806 - Safety and Efficacy Study of Etanercept (Enbrel®) In Children With Systemic Onset Juvenile Rheumatoid Arthritis Phase 3
Completed NCT00000429 - Calcium Supplements for Bone Health in Juvenile Rheumatoid Arthritis Phase 2
Completed NCT01044823 - Use of Thermal and 3D Imaging to Quantify Arthritis N/A
Terminated NCT00029042 - Infliximab to Treat Children With Juvenile Rheumatoid Arthritis Phase 2
Withdrawn NCT00286689 - Effects of Growth Hormone in Chronically Ill Children N/A
Completed NCT00095173 - BMS-188667 in Children and Adolescents With Juvenile Rheumatoid Arthritis Phase 3
Completed NCT00001862 - TNRF:Fc to Treat Eye Inflammation in Juvenile Rheumatoid Arthritis Phase 2
Not yet recruiting NCT05114343 - Effectiveness and Feasibility of a Home-based Exercise Program for Adolescents With Juvenile Idiopathic Arthritis N/A
Terminated NCT03781375 - Etanercept Plus Methotrexate Versus Methotrexate Alone in Children With Polyarticular Course Juvenile Rheumatoid Arthritis Phase 3